Asif Ali, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 58,629 shares at $141.77 ($8.3M) on 2026-09-30, disclosed to the SEC on 2026-10-02.
Scheduled sale ($8.3M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.77 | 12,595 | $1.8M | 21.5% |
| 2 | $141.78 | 46,034 | $6.5M | 78.5% |
| Total | $141.78 avg | 58,629 | $8.3M | 100% |
| Filing → |
| PTGX | SELL | 2026-01-27 | $3.8M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $708K | — | Filing → |
| PTGX | SELL | 2025-04-23 | $81K | — | Filing → |